DM Fundamentals Class 5 Goals & Standards of Care Standards of Care Topics. CDE Coach App Download Success

Size: px
Start display at page:

Download "DM Fundamentals Class 5 Goals & Standards of Care Standards of Care Topics. CDE Coach App Download Success"

Transcription

1 DM Fundamentals Class 5 Goals & Standards of Care 2017 Beverly Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Standards of Care Topics Review the 15 Standards of Care with a focus on updated standards Keeping it Patient Centered National goals and getting to target Prevention and lifestyle interventions CDE Coach App Download Success 101 Test Questions for $9.99 Standards of Care Meds PocketCards Diabetes Ed Services All rights reserved Page 1

2 Goals and Care Delivery Systems 33 49% of pts do not meet targets for A1c, BP or lipids 14% meet targets for A1c, BP, lipids and non smoking status Substantial system level improvements are needed Delivery system is fragmented, lacks clinical info capabilities, duplicates services and is poor Why Should Zip Code Determine Life Expectancy? California Endowment look up your zip code at 1. Promoting Health Reducing Disparities in Populations Start with patient centered communication. Incorporate pt preferences, literacy, life experiences Treatment decisions timely, based on evidence and tailored to individual pt. Align care with Chronic Care Model to ensure proactive practice and informed, activated patient. Provide team based care, community involvement, decision support tools. Diabetes Ed Services All rights reserved Page 2

3 Health Disparities Tailor Treatment Consider individualized care and create environmental structures to support people with: Food insecurity Cognitive dysfunction Mental illness (2 3 x s higher rates of diabetes in schizophrenia, bipolar) HIV (meds can cause pancreatic dysfunction) Health disparities related to: Ethnicity, culture, sex, socioeconomic status 2. Classification and Diagnosis Natural History of Diabetes Yes! NO Normal FBG <100 Random <140 A1c <5.7% Prediabetes FBG Random A1c ~ % 50% working pancreas Diabetes FBG Random A1c 6.5% or + 20% working pancreas Development of type 2 diabetes happens over years or decades Updated Characterization of DM Primarily a beta cell disease Destruction of a beta cell Autoimmune or chemical induced Dysfunction of the beta cell Unable to compensate for higher levels of glucose Diabetes Ed Services All rights reserved Page 3

4 2. Screening for Hyperglycemia Pre Diabetes & Type 2 Screening Guidelines Start screening at age 45 or for anyone who is overweight (BMI 25, Asians BMI 23 ) with one or > additional risk factor: First degree relative w/ diabetes Member of a high risk ethnic population Habitual physical inactivity PreDiabetes History of heart disease Diabetes 2 Who is at Risk? (ADA Clinical Practice Guidelines) Risk factors cont d HTN BP > 140/90 HDL < 35 or triglycerides > 250 baby >9 lb History Gestational Diabetes Polycystic ovary syndrome (PCOS) Other conditions assoc w/ insulin resistance: Severe obesity, acanthosis nigricans (AN) Diabetes Ed Services All rights reserved Page 4

5 Screening for Type 2 25% of all people with diabetes are undiagnosed 50% of all Asian and Hispanic Americans are undiagnosed Most people with prediabetes are undiagnosed. The duration of glycemic burden is a strong predictor of adverse outcomes. Use Validated Diabetes Risk Test (ADA) to identify those at risk and promote behavior change action for individuals and their communities. Dentists have an excellent opportunity to find patients with undetected diabetes, since up to 30% of patients over the age of 30 seen in general dental practices have dysglycemia. Test Criteria T2 Kids & Adolescents Overweight plus any two: Family history type 2 in 1 st or 2 nd degree relative Race/ethnicity Signs of insulin resistance or conditions associated with insulin resistance Maternal history of diabetes or GDM Start testing at 10 yrs or onset of puberty Recheck every 3 years or if symptoms A1c preferred screening method Diabetes Ed Services All rights reserved Page 5

6 3. Comprehensive Medical Evaluation, Assessment of Comorbidities It is necessary to take into account all aspects of a patient s life circumstance A team approach is important to integrate medical eval, patient engagement and lifestyle changes. 3. Keep it Patient Centered it is clear that optimal diabetes management requires an organized, systematic approach and the involvement of a coordinated team of dedicated health professionals, working in an environment where patient centered care is a high priority. Coordinate care as patients transition through different stages of life. Pt Centered Collaborative Care Use communication style that: Uses active listening Elicits patients preferences and beliefs Assess literacy, numeracy and barriers to care Optimize Patient health outcomes Health related quality of life Diabetes Ed Services All rights reserved Page 6

7 3. Foundations of Care and Comprehensive Medical Evaluation Medical Evaluation 1. Classify diabetes 2. Detect diabetes complications 3. Review previous treatment and risk factor control 4. Assist in formulating a management plan 5. Provide a basis for continuing care 3. Initial Eval Looking for Comorbidities Type 1 Autoimmune diseases Other conditions that may appear Type 1 /2 Depression and anxiety Obstructive sleep apnea Fatty liver disease Cancer Fractures Cognitive impairment Low Testosterone in Men Periodontal disease Hearing Impairment 4. LifeStyle Management Education Setting Up Successful Diabetes Ed Program Level 2 Nutrition Physical Activity Nutrition and Exercise Course Level 1 Smoking Cessation Psychosocial Care Immunization Diabetes Ed Services All rights reserved Page 7

8 4. Lifestyle Management Patients with prediabetes Refer to behavioral counseling /DSME program to: Focus on intensive diet and physical activity Weight loss target of 7% Increase physical activity to 150 minutes a week Follow up counseling critical for success Consider Metformin for type 2 prevention if A1c Especially with BMI >35 and hx of GDM Monitor annually and screen and mitigate modifiable CV risk factors Physical Activity Children with diabetes 60 mins / day Adults 150 min/wk moderate intensity over 3 days a week. Don t miss > 2 consecutive days w/out exercise Get up every 30 mins Reduce sedentary time T1 and T2 resistance training 2 3 xs a week Flexibility and balance training 2 3 xs a week (Yoga and Tai Chi) Best Shake For People with Diabetes From Debbie Nagata s slide collection Diabetes Ed Services All rights reserved Page 8

9 4. Goals of Medical Nutrition Therapy ADA Promote and support healthful eating patterns Emphasize eating a variety of nutrient dense foods in appropriate portions to: Attain individualized B/P, BG and lipid goals Attain and maintain body wt goals Delay and/or prevent complications Address individual nutrition needs based on personal and cultural preferences, access to food, willingness and barriers Maintain pleasure of eating by providing positive messages about food Limit food choices only when backed by science Provide practical tools for day to day planning Medical Nutrition Therapy Individualize MNT for all people with Type 1 and Type 2 Diabetes For those on flexible insulin program, provide education on carb counting, fat and protein gm estimations For those on fixed insulin program, focus on consistent carb intake considering timing and amount to improve BG control and reduce risk of hypo Diabetes Nutrition Therapy Emphasize on portion control and health food choices for: For type 2 not on insulin Pts with limited health literacy or numeracy Elderly prone to hypoglycemia Diabetes Nutrition Therapy benefits Cost savings Improved outcomes reduces A1c 1 2% Should be reimbursed by insurance Diabetes Ed Services All rights reserved Page 9

10 4. Sodium, Fat and Fiber Sodium Try and keep less than 2,300 mg a day Vitamin and mineral supplements not recommended lack of evidence. Fat same as recommended for general population Less than 10% saturated fat, Limit trans fats Less than 300 mg cholesterol daily Mediterranean Diet looks like good option Fiber gms a day 4. E Cigarettes Not supported as an alternative to smoking or to facilitate smoking cessation. Encourage all patients not to use cigarettes, other tobacco products, e cigs Provide counseling The uptake of e-cigarettes, which use battery-powered cartridges to produce a nicotine-laced vapor (and often contain other bad stuff) Psychosocial Care Provide to all pts with diabetes Integrate with a collaborative, pt centered approach. Routinely screen for depression, diabetes distress, anxiety, disordered eating and cognitive capacities Evaluate adults over 65 years for cognitive impairment and depression Diabetes Ed Services All rights reserved Page 10

11 DiabetesEd.Net Website We have posted Clinical Practice Guidelines here Resources >> Articles >> Practice Guidelines 5. Prevention of Diabetes Medicare will start funding approved Diabetes Prevention Programs 2018 Who would be Eligible? Diabetes Ed Services All rights reserved Page 11

12 CDC Diabetes Prevention Program Standard Group 29% developed DM Lifestyle Results 14% developed DM 58% (71% for 60yrs +) Risk reduction 30 mins daily activity 5 7% of body wt loss Metformin 850 BID 22% developed DM 31% risk reduction (less effective with elderly and thinner pt s) Weight loss and Prevention For every 2.2 pounds of weight loss, risk of type 2 diabetes was reduced by 13%. Have Pre Diabetes? Steps to Prevent Type 2 Lose 7% of body weight Healthy eating, high fiber, low fat, avoid sugar sweetened beverages, reduce total caloric intake Exercise 150 minutes a week Consider Metformin Therapy for Women with history of GDM Patients with BMI of 35 or greater Under the age of 60 Follow up and group education Annual monitoring and tx of CVD risk factors Diabetes Ed Services All rights reserved Page 12

13 DSM Education & Support All people with diabetes and pre diabetes should receive DSME at diagnosis and as needed Pt centered, respectful, responsive to individual pt preferences, needs, values Address psychosocial issues and emotional well being Effective self management results in cost savings, improved outcomes, health status and quality of life. Should be monitored as part of care 5. Use Technology to Prevent Diabetes Recent studies support content delivery through virtual small groups, internet social networks, cell phones and mobile devices. Validated studies that these approaches can: Support wt loss Reduce A1c (prediabetes) The CDC Diabetes Prevention Program is incorporating these tools into their program content 6. Glucose Goals Individualize Targets ADA Pre Prandial BG rather than mg/dl, to better reflect new data comparing actual average glucose levels with A1C targets. 1 2 hr post prandial < than 180 *for nonpregnant adults Diabetes Ed Services All rights reserved Page 13

14 6. A1c Glycemic Targets Adult non pregnant A1c goals A1c < 7% a reasonable goal for adults. A1c < 6.5% may be appropriate for those without significant risk of hypoglycemia or other adverse effects of treatment. A1c < 8% may be appropriate for patients with history of hypoglycemia, limited life expectancy, or those with longstanding diabetes and vascular complications. 6. A1c and Estimated Avg Glucose (eag) A1c (%) eag Order teaching tool kit free at diabetes.org eag = 28.7 x A1c 46.7 ~ 29 pts per 1% Translating the A1c Assay Into Estimated Average Glucose Values ADAG Study Diabetes Care: 31, #8, August 2008 Diabetes Ed Services All rights reserved Page 14

15 6. Pediatric Glycemic Targets A1c goal <7.5 % for all ages; however individualization is still encouraged. A lower goal, <7% if can be achieved w/out excessive hypoglycemia Blood glucose goals Before meals: Bedtime/overnight: Significant Hypoglycemia BG < 54mg/dl is defined as serious clinically significant hypoglycemia, whether that level is associated with symptoms or not. ALL pts with BG levels less than 54 mg/dl: Need Glucagon Emergency Kit Should notify their provider and health team of this significant hypoglycemia, so changes can be immediately made to their medication and treatment plan. BG <70mg/dl still considered the hypoglycemic threshold. Pts should follow the 15/15 rule and contact their provider to make any needed changes treatment plan. 7. Obesity Management for Treatment of Type 2 Diabetes This section updates (metabolic) bariatric surgery recommendations. At each pt encounter, calculate BMI and document in medical record Diabetes Ed Services All rights reserved Page 15

16 Weight Loss is Important Type 2 Strong evidence that in overwt/obese pts, a 5% initial body wt loss: Delays progression from Pre diabetes to Diabetes Improves glycemic control Improve triglycerides Reduces need for medications Optimal goal Sustained weight loss of 7% How to Achieve Weight Loss? Diet, physical activity and behavioral therapy (80% diet, 20% exercise) Interventions should be high intensity (16+ sessions in 6 months) Goal: kcal/day energy deficit (3,500 kcals = 1 pound) What is 500 kcals? 4 slices bacon, a Big Mac, bagel w/ cream cheese, 4 oz s tortilla chips, 3 sodas, 9 Oreo cookies, blueberry muffin 5 apples, 5 bananas, 5 eggs, 3 cups of beans, 1 cup almonds Long Term Weight Loss is the Goal Comprehensive wt loss maintenance program prescription: Provide monthly contact Encourage ongoing body weight monitoring (weekly) Continued consumption of reduced calorie diet Participation in high levels of physical activity: minutes a week minutes, 5 times a week Diabetes Ed Services All rights reserved Page 16

17 Metabolic (Bariatric) Surgery 2017 Consider for adults with; BMI 40 + (37.5 for Asian Americans, AA) regardless of BG control BMI ( for AA) when hyperglycemia is inadequately controlled despite lifestyle an optimal therapy BMI ( for AA) if hyperglycemia is inadequately controlled despite optimal medical control by either oral or injectable medications. Metabolic surgery should be performed at high volume center with an experienced team Need life long support and monitoring Provide comprehensive mental health assessment prior to surgery and mental health support on an ongoing basis. Metabolic Surgery Benefits Increases gut hormone availability More likely to cause remission* with recently diagnosed diabetes (more beta cell mass) 30 63% remission over 1 5 years 35 50% redeveloped diabetes Avg remission time 8.3 years Most pts who undergo surgery maintain substantial improvement of BG control from baseline for ~5 yrs Trials demonstrate metabolic surgery achieves superior BG control and reduction of CV risk factors in obese pts with type 2 compared to lifestyle/medical intervention Improvements in micro and macro disease and cancer have been observed. Procedure may reduce long term mortality *remission = BG levels normal without meds Section 8 Pharmacologic Approaches to Glycemic Treatment Insulin Cost This section was updated to include the increasing cost of Insulin see chart which reviews the average wholesale price per 1000 units of insulin and options for lower cost insulin therapy. Includes insulin therapy strategies for type 1 / type 2 Metformin & B12 For patients on long term metformin therapy, the ADA recommends periodic B12 measurement and supplementation as needed. CV Disease For patients with cardiovascular disease, consider using empagliflozin or liraglutide to reduce the risk of cardiovascular events. Diabetes Ed Services All rights reserved Page 17

18 ADA Step Wise Approach to Hyperglycemia 2017 Start lifestyle coaching and metformin therapy Metformin is effective, safe, affordable, lowers CV Risk If A1c target not achieved after 3 mos, start 2 nd med/ins If A1c target not achieved after 3 mos, add 3 rd agent If A1c target not achieved after 3 mos, add basal insulin If A1c target not achieved after 3 mos, keep metformin, consider adding bolus insulin, or switching to GLP 1 RA + Basal, or premixed insulin A1c 9% consider initiating dual therapy or insulin if A1c 10% consider initiating combo insulin therapy Diabetes Ed Services All rights reserved Page 18

19 EMPA REG OUTCOME : Summary Empagliflozin, as used in this trial, for 3 years in 1,000 patients with type 2 diabetes at high CV risk: Empagliflozin reduced hospitalization for heart failure 35% Empagliflozin reduced CV death by 38% Empagliflozin improved survival by reducing allcause mortality by 32% 8. Insulin Management for Type 2 8. Pharmacologic Approaches to Glycemic Management Join our Meds for Type 2 (Part 1) in Level 1 Series Join our Meds Management for Type 2 (Part 2) in Level 2 Series Join Insulin Pattern Management (Part 1) in Level 1 Series Insulin Pattern Mgmt Gone Crazy (Part 2) in Level 2 Series Diabetes Ed Services All rights reserved Page 19

20 New PocketCards 2 Styles ABC s of Diabetes A1C Blood Pressure Cholesterol 9. Cardiovascular Disease and Risk Management Cardiovascular disease is the leading cause of mortality and morbidity in diabetes Largest contributor to direct and indirect costs Controlling cardiovascular risk improves outcomes Large benefits are seen when multiple risk factors are addressed globally Diabetes Ed Services All rights reserved Page 20

21 9. BP Goal BP < 140 / 90 Some pts may benefit from B/P 130/80 (younger and achieved with undue tx burden) Studies indicate that the previous B/P target of 140/80 didn t improve outcomes enough to balance the risk of side effects such as orthostatic hypotension and polypharmacy. 9. Hypertension Guidelines Screening Check BP at each visit. If either systolic 140 or > diastolic 90 or > repeat on separate day. Hypertension = Repeat systolic or diastolic above or equal to these levels When taking B/P Pt sit still for 5 min s Feet on floor, Arm supported at heart level Right size cuff 9. Blood Pressure Treatment First Line B/P Drugs Any of the 4 classes of BP meds can be used to tx hypertension (without albuminuria). This includes ACE Inhibitors, ARBs, thiazide like diuretics or calcium channel blockers. Multiple Drug Therapy often required For best effect, administer at least one at bedtime Diabetes Ed Services All rights reserved Page 21

22 Antiplatelet Agents Consider aspirin therapy ( mg/day) As a primary prevention strategy for T1 or T2 at increase CV risk (10 yr risk >10%) In pts who can t tolerate, use Plavix, (clopidogrel) Combo therapy of aspirin + clopidogrel is reasonable for a year after MI Includes most men or women w DM age 50 years, with at least 1 additional risk factor: Family history of premature ASCVD Hypertension Smoking Dylipidemia Albuminuria 9. Coronary Heart Disease In pts with known CVD, use: Aspirin Statin B/P Med Consider ACE Inhibitor to reduce risk of CV event In pts with prior MI, Beta Blockers should be continued at least 2 years after the event Don t use Actos or Avandia in pts with CHF In pts with stable CHF, Metformin can be used in renal function normal and stable A 78 yr old man, smokes ppd A1c was 8.1% (down from 10.4%) B/P 136/76 AM BG 100, 2 hr pp 190 Chol TG 54, HDL 46, LDL 98 Meds: Insulin 16 units Lantus at HS Benazepril 20 mg Metropolol 50mg Warfarin 5mg Actos 15 mg What class of meds is this patient on? Any special instructions? Any med missing? Diabetes Ed Services All rights reserved Page 22

23 ABCs of Diabetes A1c less than 7% (avg 3 month BG) Pre meal BG Post meal BG <180 Blood Pressure < 140/90 Cholesterol Eval if statin therapy indicated Mr. Jones What are Your Recommendations for Self Care? Patient Profile 62 yr old with newly dx type 2. History of previous MI. Meds: Lasix, synthroid Labs: A1c 9.3% HDL 37 mg/dl LDL 156 mg/dl Triglyceride 260mg/dl Proteinuria neg B/P 142/92 Self Care Skills Walks dog around block 3 x s a week Bowls every Friday Widowed, so usually eats out 10. Microvascular Complications "Every time you see your doctor, take off your shoes and socks and show your feet!" For patients with loss of protective sensation, foot deformities, or a history of foot ulcers Comprehensive foot eval each year to identify risk & promote prevention Diabetes Ed Services All rights reserved Page 23

24 10. Microvascular Complications Nephropathy Diabetic Kidney Disease Optimize glucose and B/P Control to protect kidneys Screen for Albumin Creat ratio and GFR Type 2 at dx then yearly Type 1 with diabetes for 5 years, then yearly Treat hypertension with ACE or ARB and intensify as needed Consider referral to specialist when management is difficult and kidney disease is advanced Not recommended to limit dietary protein intake below 0.8 g/kg/day (doesn t improve outcomes) See Level 2 Course, Microvascular Complications 10. Microvascular Complications Eye Disease Optimize glucose and B/P Control to protect eyes Screen with initial dilated and comprehensive eye exam by ophthalmologist or optometrist Type 2 at diagnosis, then every one to 2 years Type 1 within 5 years of dx, then every 1 2 years Can use high quality fundus photography as screening tool Initial exam should be done in person Promptly refer pts with macular edema, severe non proliferative disease trained specialist Treatment includes laser therapy (retinopathy) and Antivascular and Endothelial Growth Factor for Macular Edema 10. Microvascular Complications Nerve Disease Tight glycemic control Medication recommendations updated Screen all patients for nerve disease using simple tests, such as a monofilament Type 2 at diagnosis, then annually Type 1 diabetes 5 years, then annually Assess and treat patients to reduce pain and symptoms to improve quality of life. Diabetes Ed Services All rights reserved Page 24

25 11. Older Adults 26% of people over 65 have diabetes (expected to rise) Asses the medical, functional, mental and social geriatric domains for diabetes. Provide individualized care Determine targets and therapeutic approaches Over age 65, high risk for depression Provide nursing home staff with education See Level 2 Course, Older Adults and Diabetes Older Adults ( 65 years) with diabetes Annual screening for early detection of mild cognitive impairment or dementia High priority population for depression screening and treatment Avoid hypoglycemia in this high risk group Prevent hypo by adjusting glycemic targets and adjusting pharmacologic interventions 12. Children and Adolescents Start preconception counseling at puberty for all girls of childbearing potential decreases risk of malformations associated with unplanned pregnancies and poor metabolic control, Type 1 or Type 2 Diabetes? Many children are overweight with new See Level 2 Course - Kids hyperglycemia. and Diabetes for full detail 6% of children with new type 2 present in DKA. Type 2 in kids is different than type 2 in adults, including more rapid decline in beta cell function and accelerated development of diabetes complications. Evaluate autoantibodies and do a careful history to determine the correct diagnosis and provide early and appropriate treatment. Diabetes Ed Services All rights reserved Page 25

26 13. Gestational DM ~ 7% of all Pregnancies GDM prevalence increased by % during the past 20 yrs Native Americans, Asians, Hispanics, African American women at highest risk Immediately after pregnancy, 5% to 10% of GDM diagnosed with type 2 diabetes Within 5 years, 50% chance of developing DM in next 5 years. 13. Meds used in Pregnancy Insulin is the preferred med to be used in pregnancy Glyburide and Metformin cross the placenta Long term studies needed 14. Diabetes Care in Hospital, Nursing Home and Skilled Nursing Facility Get A1c on all patient with DM/hyperglycemia Start discharge planning on admission Avoid sole use of sliding scale insulin during hospital stay Basal bolus preferred treatment Have hypoglycemia protocol Clearly identify type of diabetes on admission Inpatient glucose goals: Start insulin if BG >180 Goal BG (some pts may benefit from ) New Parenteral/Enteral Feeding Chart Diabetes Ed Services All rights reserved Page 26

27 Parenteral/Enteral Feeding Chart 15. Diabetes Advocacy People living with diabetes should not face discrimination We need to all be a part of advocating for the best care and the rights of people living with diabetes. DiabetesEd.net > Resources Diabetes Ed Services All rights reserved Page 27

28 Thank You Please us with any questions. Diabetes Ed Services All rights reserved Page 28

Standards of Care Topics

Standards of Care Topics Diabetes Boot Camp Class 2 Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Standards of Care 2017 www.diabetesed.net Standards of Care Topics Review the 15 Standards

More information

Standards of Medical Care In Diabetes

Standards of Medical Care In Diabetes Standards of Medical Care In Diabetes - 2017 Robert E. Ratner, MD, FACP, FACE Professor of Medicine Georgetown University School of Medicine Disclosed no conflict of interest Standards of Care Professional.diabetes.org/SOC

More information

STATE OF THE STATE: TYPE II DIABETES

STATE OF THE STATE: TYPE II DIABETES STATE OF THE STATE: TYPE II DIABETES HENRY DRISCOLL, MD, CHIEF of ENDOCRINOLOGY MARSHALL U, CHERTOW DIABETES CENTER, HUNTINGTON VAMC HEATHER VENOY, RD, LD, CDE DIETITIAN, DIABETES EDUCATOR, CHERTOW DIABETES

More information

Welcome to Diabetes MiniSeries Course 2

Welcome to Diabetes MiniSeries Course 2 Welcome to Diabetes MiniSeries Course 2 Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Copyright 1999 2014, Diabetes Education Services, All Rights Reserved. Diabetes

More information

Standards of Medical Care in Diabetes 2016

Standards of Medical Care in Diabetes 2016 Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking

More information

Standards of Medical Care in Diabetes 2018

Standards of Medical Care in Diabetes 2018 Standards of Medical Care in Diabetes 2018 Eric L. Johnson, M.D. Associate Professor University of North Dakota School of Medicine and Health Sciences Assistant Medical Director Altru Diabetes Center Grand

More information

American Diabetes Association: Standards of Medical Care in Diabetes 2015

American Diabetes Association: Standards of Medical Care in Diabetes 2015 American Diabetes Association: Standards of Medical Care in Diabetes 2015 Synopsis of ADA standards relevant to the 11 th Scope of Work under Task B.2 ASSESSMENT OF GLYCEMIC CONTROL Recommendations: Perform

More information

Clinical Practice Guidelines for Diabetes Management

Clinical Practice Guidelines for Diabetes Management Clinical Practice Guidelines for Diabetes Management Diabetes is a disease in which blood glucose levels are above normal. Over the years, high blood glucose damages nerves and blood vessels, which can

More information

What s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center

What s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center What s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center Learning Objectives By the end of this presentation, participants should be able to: Discuss updates

More information

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures

More information

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Standards of Care in Diabetes 2016-- What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Terminology No longer using the term diabetic. Diabetes does not define people. People

More information

STANDARDS OF MEDICAL CARE IN DIABETES 2014

STANDARDS OF MEDICAL CARE IN DIABETES 2014 STANDARDS OF MEDICAL CARE IN DIABETES 2014 I. CLASSIFICATION AND DIAGNOSIS Classification of Diabetes Type 1 diabetes β-cell destruction Type 2 diabetes Progressive insulin secretory defect Other specific

More information

Modified version focused on CCNC Quality Measures and Feedback Processes

Modified version focused on CCNC Quality Measures and Feedback Processes Executive Summary: Standards of Medical Care in Diabetes 2010 Modified version focused on CCNC Quality Measures and Feedback Processes See http://care.diabetesjournals.org/content/33/supplement_1/s11.full

More information

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE Management of DM in Older Adults: It s not all about sugar! Peggy Odegard, Pharm.D., BCPS, CDE Who needs treatment for DM? 87 year old, frail male with moderately severe dementia living in NH with persistent

More information

Key Elements in Managing Diabetes

Key Elements in Managing Diabetes Key Elements in Managing Diabetes Presentor Disclosure No conflicts of interest to disclose Presented by Susan Cotey, RN, CDE Lennon Diabetes Center Stephanie Tubbs Jones Health Center Cleveland Clinic

More information

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes

More information

Adult Diabetes Clinician Guide NOVEMBER 2017

Adult Diabetes Clinician Guide NOVEMBER 2017 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Diabetes Clinician Guide Introduction NOVEMBER 2017 This evidence-based guideline summary is based on the 2017 KP National Diabetes Guideline.

More information

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet

More information

Diabetes Mellitus: Evaluation and Care Management

Diabetes Mellitus: Evaluation and Care Management Diabetes Mellitus: Evaluation and Care Management Michael King, MD Assistant Professor Residency Program Director University of Kentucky Dept. of Family & Community Medicine Learning Objectives 1. Review

More information

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents

More information

Executive Summary: Standards of Medical Care in Diabetes 2010

Executive Summary: Standards of Medical Care in Diabetes 2010 E X E C U T I V E S U M M A R Y Executive Summary: Standards of Medical Care in Diabetes 2010 Current criteria for the diagnosis of diabetes A1C 6.5%: The test should be performed in a laboratory using

More information

Diabetes Summary of Medical Guidelines

Diabetes Summary of Medical Guidelines Diabetes Summary of Medical Guidelines Key concepts in setting glycemic controls: goals should be individualized; certain populations (children, pregnant women, and elderly) require special considerations;

More information

Topics. Page 1. Web Clinic Details. Copyright , Diabetes Educational Services, All Rights. Welcome to Preparing for BC-ADM Exam 2012

Topics. Page 1. Web Clinic Details. Copyright , Diabetes Educational Services, All Rights. Welcome to Preparing for BC-ADM Exam 2012 Welcome to Preparing for BC-ADM Exam 2012 Presented by Beverly Thomassian, RN, MPH, BC-ADM, CDE Diabetes Educational Services www.diabetesed.net Web Clinic Details To hear presentation, turn on your computer

More information

DIABETES MEASURES GROUP OVERVIEW

DIABETES MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: DIABETES MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN DIABETES MEASURES GROUP: #1. Diabetes: Hemoglobin A1c Poor Control #2. Diabetes: Low Density Lipoprotein (LDL-C)

More information

The National Diabetes Prevention Program in Washington State March 2012

The National Diabetes Prevention Program in Washington State March 2012 The National Diabetes Prevention Program in Washington State March 2012 Session Objectives 1. Overview of pre-diabetes. 2. Describe the Diabetes Prevention Program (DPP). 3. Eligibility for the DPP. 4.

More information

Diabetes Mellitus Case Study

Diabetes Mellitus Case Study COLORADO STATE UNIVERSITY Diabetes Mellitus Case Study Medical Nutrition Therapy By: Emily Lancaster 9/28/2012 [Type the abstract of the document here. The abstract is typically a short summary of the

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

Course Objectives. Diabetes Fundamentals Series Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services

Course Objectives. Diabetes Fundamentals Series Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Diabetes Fundamentals Series Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services 2017 Welcome to Diabetes Fundamentals Series of 6 courses designed to provide you with

More information

American Diabetes Association 2018 Guidelines Important Notable Points

American Diabetes Association 2018 Guidelines Important Notable Points American Diabetes Association 2018 Guidelines Important Notable Points The Standards of Medical Care in Diabetes-2018 by ADA include the most current evidencebased recommendations for diagnosing and treating

More information

Diabetes and the Heart

Diabetes and the Heart Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with

More information

2018 Standard of Medical Care Diabetes and Pregnancy

2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy Marjorie Cypress does not have any relevant financial relationships with any commercial interests

More information

Clinical Practice Guideline Key Points

Clinical Practice Guideline Key Points Clinical Practice Guideline Key Points Clinical Practice Guideline 2008 Key Points Diabetes Mellitus Provided by: Highmark Endocrinology Clinical Quality Improvement Committee In accordance with Highmark

More information

Physical Activity/Exercise Prescription with Diabetes

Physical Activity/Exercise Prescription with Diabetes Physical Activity/Exercise Prescription with Diabetes B R AD H I NTERMEYER C E P A C SM S A NFORD H E ALTH C A RDIAC R E H AB A N D D I ABE TES E XE RCISE The adoption and maintenance of physical activity

More information

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1 Welcome Everyone Sign-In Enjoy Breakfast Meet someone new Enter Raffle Pick a team name Please silence phones We start at 8:00am Monitoring, Sick Days, Inpatient Management - Objectives Objectives: Strategies

More information

Page 0 of 20. Health Profiles. Diabetes Montgomery County, OH. Public Health - Dayton & Montgomery County Epidemiology Section

Page 0 of 20. Health Profiles. Diabetes Montgomery County, OH. Public Health - Dayton & Montgomery County Epidemiology Section Page 0 of 20 Health Profiles Diabetes Montgomery County, OH Public Health - Dayton & Montgomery County Epidemiology Section January 2014 Page 1 of 20 Prepared by: Epidemiology Section of Public Health

More information

Diabetes and Hypertension

Diabetes and Hypertension Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for

More information

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for Section 1: 1: Trends 1 Patients in the Diabetes Register 2 Gender of Patients with Diabetes 2 Age of Patients with Diabetes 3 Diabetes Type 3 Duration of Diabetes 4 Weight Control 5 Hemoglobin A1c 6 Blood

More information

DIABETES. A growing problem

DIABETES. A growing problem DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought

More information

Executive Summary: Standards of Medical Care in Diabetes 2009

Executive Summary: Standards of Medical Care in Diabetes 2009 Executive Summary Executive Summary: Standards of Medical Care in Diabetes 2009 Current Criteria for the Diagnosis of Diabetes Fasting plasma glucose (FPG) 126 mg/dl (7.0 mmol/l). Fasting is defined as

More information

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes

More information

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives.

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Vipul Lakhani, MD Oregon Medical Group Endocrinology

Vipul Lakhani, MD Oregon Medical Group Endocrinology Vipul Lakhani, MD Oregon Medical Group Endocrinology Disclosures None Objectives Be able to diagnose diabetes and assess control Be able to identify appropriate classes of medications for diabetes treatment

More information

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes? What is Diabetes? Diabetes 101 Ginny Burns RN MEd CDE Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action

More information

Presenter Disclosure Information

Presenter Disclosure Information Prediabetes & Type 2 Diabetes Prevention Cari Ritter, PA-C Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure

More information

Monthly WellPATH Spotlight November 2016: Diabetes

Monthly WellPATH Spotlight November 2016: Diabetes Monthly WellPATH Spotlight November 2016: Diabetes DIABETES RISK FACTORS & SELF CARE TIPS Diabetes is a condition in which the body does not produce enough insulin or does not use the insulin produced

More information

Diabetes Education 1/23/2014

Diabetes Education 1/23/2014 Diabetes Education JESSICA GOECKING MS RD LD OUTPATIENT DIETITIAN UT HEALTH NORTHEAST TYLER, TEXAS What is Diabetes? Diabetes is a group of diseases characterized by high levels of blood glucose (blood

More information

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes Pre-diabetes Pharmacological Approaches to Delay Progression to Diabetes Overview Definition of Pre-diabetes Risk Factors for Pre-diabetes Clinical practice guidelines for diabetes Management, including

More information

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS Dr Bidhu Mohapatra, MBBS, MD, FRACP Consultant Physician Endocrinology and General Medicine Introduction 382 million people affected by diabetes

More information

Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico

Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico Presented in Collaboration with New Mexico Health Care Takes On Diabetes Discuss the burden and challenges prediabetes presents in New Mexico.

More information

Nutritional Recommendations for the Diabetes Managements

Nutritional Recommendations for the Diabetes Managements In the name of God Nutritional for the Diabetes Managements Zohreh Mazloom. PhD Shiraz University of Medical Sciences School of Nutrition and Food Sciences Department of Clinical Nutrition OVERVIEW Healthful

More information

Sect S io ecn ti 1 o : n Trend 1: Tres nds

Sect S io ecn ti 1 o : n Trend 1: Tres nds Section 1: 1: Trends 1 Patients in the Diabetes Register 2 Gender of Patients with Diabetes 2 Age of Patients with Diabetes 3 Diabetes Type 3 Duration of Diabetes 4 Weight Control 5 Hemoglobin A1c 6 Blood

More information

Living with Diabetes

Living with Diabetes Living with Diabetes You Are Not Alone! Diabetes continues to grow each year at an alarming rate in the United States. According to the Centers for Disease Control and Prevention (CDC), nearly 30 million

More information

Diabetes Survival Skills

Diabetes Survival Skills Promoting Patient Survival with Diabetes Survival Skills Need to know skills for persons with diabetes Susan Zontine, NP-C WMC Diabetes Stewardship team May 18, 2015 Diabetes Chronic illness with serious

More information

Diabetes Updates. Disclosures

Diabetes Updates. Disclosures Diabetes Updates Dr. Thanh D. Hoang, DO, FACP, FACE Walter Reed National Military Medical Center Associate Professor of Medicine Uniformed Services University of the Health Sciences March 2018 Disclosures

More information

Living Well with Diabetes

Living Well with Diabetes Living Well with Diabetes What is diabetes? Diabetes Overview Diabetes is a disorder of the way the body uses food for growth and energy. Most of the food people eat is broken down into glucose, the form

More information

Application of the Diabetes Algorithm to a Patient

Application of the Diabetes Algorithm to a Patient Application of the Diabetes Algorithm to a Patient Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent

More information

Session 21: Heart Health

Session 21: Heart Health Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk

More information

A Summary Report: 2003

A Summary Report: 2003 D iabetes in Idaho A Summary Report: 2003 Idaho Department of Health and Welfare Division of Health Bureau of Community and Environmental Health This publication was supported by Grant No. U32/CCU022691-02

More information

Jennifer Loh, MD, FACE Chief of Endocrinology KP Hawaii AAMD of Medical Education, KP Hawaii

Jennifer Loh, MD, FACE Chief of Endocrinology KP Hawaii AAMD of Medical Education, KP Hawaii Individualized Diabetes Treatment for the Elderly Jennifer Loh, MD, FACE Chief of Endocrinology KP Hawaii AAMD of Medical Education, KP Hawaii Extremely Relevant Baby Boomers are aging! ¼ of people age

More information

Diabetes Update: Diabetes Management In Primary Care. Jonathon M. Firnhaber, MD, FAAFP

Diabetes Update: Diabetes Management In Primary Care. Jonathon M. Firnhaber, MD, FAAFP Diabetes Update: Diabetes Management In Primary Care Jonathon M. Firnhaber, MD, FAAFP Learning objectives 1. Critically evaluate the evidence emerging within diabetes research as it applies to recommendations

More information

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Points to Ponder ASCVD is the leading cause of morbidity

More information

Medical Nutrition Therapy & Nutrition Ed in DSMES What s the Difference?

Medical Nutrition Therapy & Nutrition Ed in DSMES What s the Difference? Medical Nutrition Therapy & Nutrition Ed in DSMES What s the Difference? MEGAN ELLISON, MS, RDN, CSOWM, CDE WADE CONFERENCE APRIL 25, 2019 1 Disclosure to Participants Notice of Requirements for Successful

More information

An Update on the Standards of Medical Care in Diabetes 2017, With an Eye Toward 2018

An Update on the Standards of Medical Care in Diabetes 2017, With an Eye Toward 2018 An Update on the Standards of Medical Care in Diabetes 2017, With an Eye Toward 2018 Erika Gebel Berg, PhD Director, Scientific and Medical Affairs Corresponding Author, ADA s Standards of Medical in Diabetes

More information

NEW DIABETES CARE MEDICATIONS

NEW DIABETES CARE MEDICATIONS NEW DIABETES CARE MEDICATIONS James Bonucchi DO, ECNU, FACE Adult Medicine and Endocrinology Specialists Disclosures Speakers bureau Sanofi AZ BI Diabetes Diabetes cost ADA 2017 data Ever increasing disorder.

More information

It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia

It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia Jacqueline LaManna, PhD, ANP BC, BC ADM, CDE Holly Divine, PharmD, BCACP, CGP, CDE, FAPhA Disclosures Dr. Jacqueline LaManna

More information

Diabetes Audit Results, Portland Area, Site-Specific Trends

Diabetes Audit Results, Portland Area, Site-Specific Trends Site-Specific Trends The following report contains information from your program's annual diabetes audit submission to the Indian Health Service over the past few years. The report was prepared for your

More information

Diabetes Meds Update Disclaimer and Important Info. Objectives. Page 1. Copyright , Diabetes Education Services

Diabetes Meds Update Disclaimer and Important Info. Objectives. Page 1. Copyright , Diabetes Education Services Diabetes Meds Update 2016 Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Disclaimer and Important Info This content is for educational purposes only. Please see Package

More information

Guiding Principles. for Diabetes Care: For Health Care. Providers

Guiding Principles. for Diabetes Care: For Health Care. Providers Guiding Principles N A T I O N A L for Diabetes Care: D I A B E T E S For Health Care E D U C A T I O N Providers P R O G R A M The National Diabetes Education Program (NDEP) has developed these Guiding

More information

Common Diabetes-related Terms

Common Diabetes-related Terms Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes

More information

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Index Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication GAD glutamic acid decarboxylase GLP-1 glucagon-like peptide 1 NPH neutral

More information

Clinical Recommendations: Patients with Periodontitis

Clinical Recommendations: Patients with Periodontitis The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;

More information

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for Section 1: 1: Trends 2 Patients in the Diabetes Register 3 Diabetes Type 3 Gender of Patients with Diabetes 4 Age of Patients with Diabetes 4 Duration of Diabetes 5 Weight Control 6 Hemoglobin A1c 7 Blood

More information

9/28/2012. Sponsored By: NDSU College of Pharmacy, Nursing and Allied Sciences

9/28/2012. Sponsored By: NDSU College of Pharmacy, Nursing and Allied Sciences Sponsored By: NDSU College of Pharmacy, Nursing and Allied Sciences By PresenterMedia.com Faculty: Wendy Brown Pharm.D, PA-C, AE-C Associate Professor Pharmacy Practice About the Patient Clinical Coordinator

More information

Wayne Gravois, MD August 6, 2017

Wayne Gravois, MD August 6, 2017 Wayne Gravois, MD August 6, 2017 Americans with Diabetes (Millions) 40 30 Source: National Diabetes Statistics Report, 2011, 2017 Millions 20 10 0 1980 2009 2015 2007 - $174 Billion 2015 - $245 Billion

More information

Diabetes Mellitus in Older Adults. Presenter Disclosure Information

Diabetes Mellitus in Older Adults. Presenter Disclosure Information Diabetes Mellitus in Older Adults Medha Munshi, M.D. Joslin Diabetes Center Beth Israel Deaconess Medical Center Harvard Medical School Presenter Disclosure Information Medha Munshi Research grant from

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

RCHC Clinical Guidelines Type 2 Diabetes; Adults

RCHC Clinical Guidelines Type 2 Diabetes; Adults RCHC Clinical Guidelines Type 2 Diabetes; Adults Screening for diabetes in asymptomatic adults 1 Population: Aged > 45 years; Aged < 45 years who are overweight (BMI> 25kg/m 2 ) and have an additional

More information

National Diabetes Fact Sheet, 2011

National Diabetes Fact Sheet, 2011 National Diabetes Fact Sheet, 2011 FAST FACTS ON DIABETES Diabetes affects 25.8 million people 8.3% of the U.S. population DIAGNOSED 18.8 million people UNDIAGNOSED 7.0 million people All ages, 2010 Citation

More information

Prediabetes 101. What is it and what can I do about it? Intermountainhealthcare.org/diabetes

Prediabetes 101. What is it and what can I do about it? Intermountainhealthcare.org/diabetes Prediabetes 101 What is it and what can I do about it? Patient Education Intermountainhealthcare.org/diabetes What do you already know about prediabetes? Fact or Fiction? There are often no symptoms of

More information

Important Stuff. Basal Bolus What Adjustments? Pt weighs 80kg

Important Stuff. Basal Bolus What Adjustments? Pt weighs 80kg Diabetes Boot Camp Class 4 Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Special Insulin and Pattern Management Diabetes Education Services 1998-2015. All rights

More information

Type 2 Diabetes in Adolescents

Type 2 Diabetes in Adolescents Type 2 Diabetes in Adolescents Disclosures Paid consultant, Eli Lilly, Inc, Pediatric Type 2 Diabetes Clinical Trials Outline The burden of diabetes Treatment and Prevention Youth Diabetes Prevention Clinic

More information

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator

More information

DIABETES SELF MANAGEMENT EDUCATION / NUTRITION COUNSELING INITIAL ASSESSMENT. NAME Today s Date

DIABETES SELF MANAGEMENT EDUCATION / NUTRITION COUNSELING INITIAL ASSESSMENT. NAME Today s Date NAME Today s Date DATE OF BIRTH CONTACT INFORMATION: Home Number Cell phone number Work Number Okay to call at work? No Yes Answering machine No Yes Ok to leave message Your own personal Email Address

More information

Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE

Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE Heavy Numbers Surgeon General report: 68% of adults in U. S. are overweight or obese

More information

Type 1 Diabetes Mellitus in the Adult. Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I

Type 1 Diabetes Mellitus in the Adult. Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I Type 1 Diabetes Mellitus in the Adult Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I Diabetes Mellitus: Type I Genetic factor Sudden onset Majority children and adolescents with an increasing

More information

Am I at Risk for Type 2 Diabetes?

Am I at Risk for Type 2 Diabetes? NATIONAL DIABETES INFORMATION CLEARINGHOUSE Am I at Risk for Type 2 Diabetes? Taking Steps to Lower Your Risk of Getting Diabetes U.S. Department of Health and Human Services National Institutes of Health

More information

Am I at Risk for Type 2 Diabetes?

Am I at Risk for Type 2 Diabetes? Am I at Risk for Type Diabetes? Taking Steps to Lower Your Risk of Getting Diabetes On this page: What is type diabetes? Can type diabetes be prevented? What are the signs and symptoms of type diabetes?

More information

Activity and Diabetes: Benefits, Precautions and Guidelines. Shay Kelly BS, MSS, BSN, CDE. Program Objectives

Activity and Diabetes: Benefits, Precautions and Guidelines. Shay Kelly BS, MSS, BSN, CDE. Program Objectives Activity and Diabetes: Benefits, Precautions and Guidelines Shay Kelly BS, MSS, BSN, CDE Program Objectives At the end of this presentation, the participant will be able to: 1. Describe how the body utilizes

More information

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??

More information

Medical Nutrition Therapy for Diabetes Mellitus. Raziyeh Shenavar MSc. of Nutrition

Medical Nutrition Therapy for Diabetes Mellitus. Raziyeh Shenavar MSc. of Nutrition Medical Nutrition Therapy for Diabetes Mellitus Raziyeh Shenavar MSc. of Nutrition Diabetes Mellitus A group of diseases characterized by high blood glucose concentrations resulting from defects in insulin

More information

Diabetes Review Chris Paras, D.O. Assistant Prof of Medicine, NYIT & Touro COM Designated Institutional Official & Assoc. Clinical Dean, Brookdale

Diabetes Review Chris Paras, D.O. Assistant Prof of Medicine, NYIT & Touro COM Designated Institutional Official & Assoc. Clinical Dean, Brookdale Diabetes Review Chris Paras, D.O. Assistant Prof of Medicine, NYIT & Touro COM Designated Institutional Official & Assoc. Clinical Dean, Brookdale University Hospital Diabetes Care 2018 Jan; 41 Objectives

More information

8/5/2017. Disclosure to Participants. Learning Outcomes. Terry Compton MS, APRN, CDE. Seniors with Diabetes: Why Are They Different?

8/5/2017. Disclosure to Participants. Learning Outcomes. Terry Compton MS, APRN, CDE. Seniors with Diabetes: Why Are They Different? Terry Compton MS, APRN, CDE Diabetes Education Program Manager St. Tammany Parish Hospital Covington, LA Sara (Mandy) Reece PharmD, CDE, BC-ADM, FAADE Diabetes Educator Vice Chair and Associate Professor,

More information

Welcome to Diabetes MiniSeries Class 1

Welcome to Diabetes MiniSeries Class 1 Welcome to Diabetes MiniSeries Class 1 Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Copyright 1999 2014, Diabetes Education Services, All Rights Reserved. Diabetes

More information

Quick Reference Guide

Quick Reference Guide 2013 Clinical Practice Guidelines Quick Reference Guide (Updated November 2016) 416569-16 guidelines.diabetes.ca diabetes.ca 1-800-BANTING (226-8464) Copyright 2016 Canadian Diabetes Association SCREENING

More information

SIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence

SIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence SIGN 149 Risk estimation and the prevention of cardiovascular disease Quick Reference Guide July 2017 Evidence ESTIMATING CARDIOVASCULAR RISK R Individuals with the following risk factors should be considered

More information

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Today s Presentation HbA1c & diagnosing Diabetes What is Impaired Glucose & IGR? Implications

More information

Diabetes Complications Guideline Based Screening, Management, and Referral

Diabetes Complications Guideline Based Screening, Management, and Referral Diabetes Complications Guideline Based Screening, Management, and Referral Eric L. Johnson, M.D. Associate Professor Department of Family and Community Medicine Assistant Medical Director Altru Diabetes

More information

Guidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010

Guidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010 Guidelines to assist General Practitioners in the Management of Type 2 Diabetes April 2010 Foreword The guidelines were devised by the Diabetes Day Centre in Beaumont Hospital in consultation with a number

More information